Filing Details

Accession Number:
0001140361-16-075000
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-08-05 14:20:11
Reporting Period:
2016-08-04
Filing Date:
2016-08-05
Accepted Time:
2016-08-05 14:20:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1444380 Nevro Corp NVRO Surgical & Medical Instruments & Apparatus (3841) 562568057
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1622421 Michael Enxing C/O Nevro Corp.
1800 Bridge Parkway
Redwood City CA 94065
Vp Of Sales No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-08-04 1,500 $3.60 39,463 No 4 M Direct
Common Stock Disposition 2016-08-04 1,500 $82.06 37,963 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2016-08-04 1,500 $0.00 1,500 $3.60
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
86,108 2022-12-17 No 4 M Direct
Footnotes
  1. The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
  2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $81.58 to $82.36, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  3. 25% of the shares subject to the option vest on the first anniversary measured from December 1, 2012 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest in thirty-six (36) successive and equal monthly installments thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.